...
首页> 外文期刊>Drug Design, Development and Therapy >Gamma scintigraphic?evaluation of floating gastroretentive tablets of metformin HCl using a combination of three natural polymers in rabbits
【24h】

Gamma scintigraphic?evaluation of floating gastroretentive tablets of metformin HCl using a combination of three natural polymers in rabbits

机译:三种二聚体在家兔中的盐酸二甲双胍胃滞留性漂浮片剂的γ闪烁显像评估

获取原文

摘要

Abstract: The present research was aimed at formulating a metformin HCl sustained-release formulation from a combination of polymers, using the wet granulation technique. A total of 16 formulations (F1–F16) were produced using different combinations of the gel-forming polymers: tamarind kernel powder, salep (palmate tubers of Orchis morio), and xanthan. Post-compression studies showed that there were no interactions between the active drug and the polymers. Results of in vitro drug-release studies indicated that the F10 formulation which contained 5 mg of tamarind kernel powder, 33.33 mg of xanthan, and 61.67 mg of salep could sustain a 95% release in 12 hours. The results also showed that F2 had a 55% similarity factor with the commercial formulation (C-ER), and the release kinetics were explained with zero order and Higuchi models. The in vivo study was performed in New Zealand White rabbits by gamma scintigraphy; the F10 formulation was radiolabeled?using samarium (III) oxide (153Sm2O3) to trace transit of the tablets in the gastrointestinal tract. The in vivo data supported the retention of F10 formulation in the gastric region for 12 hours. In conclusion, the use of a combination of polymers in this study helped to develop an optimal gastroretentive drug-delivery system with improved bioavailability, swelling, and floating characteristics.
机译:摘要:本研究旨在采用湿法制粒技术,从多种聚合物中配制盐酸二甲双胍缓释制剂。使用形成凝胶的聚合物的不同组合生产了总共16种配方(F1-F16):罗望子仁粉,salep(Orchis morio的手掌块茎)和黄原胶。压缩后研究表明,活性药物与聚合物之间没有相互作用。体外药物释放研究的结果表明,包含5 mg罗望子仁粉,33.33 mg黄原胶和61.67 mg salep的F10制剂可在12小时内维持95%的释放。结果还表明,F2与商业配方(C-ER)具有55%的相似因子,并且使用零阶模型和Higuchi模型解释了释放动力学。体内研究是通过伽玛闪烁显像法在新西兰白兔中进行的。 F10制剂用氧化sa(153Sm2O3)进行了放射性标记,以追踪片剂在胃肠道中的转运。体内数据支持F10制剂在胃区域中保留12小时。总之,在这项研究中使用多种聚合物有助于开发出具有改善的生物利用度,溶胀和漂浮特性的最佳胃滞留药物递送系统。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号